v3.26.1
Investments - Non-equity method (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Aug. 22, 2023
USD ($)
Equity Securities without Readily Determinable Fair Value [Line Items]                
Investment in equity securities $ 82,466 $ 82,466   $ 86,353        
Payment to acquire convertible notes       0 $ 2,127      
Impairment loss on investments         $ 25,000      
Infinitum                
Equity Securities without Readily Determinable Fair Value [Line Items]                
Investment in equity securities       86,400        
Payment to acquire investment $ 14,900         $ 24,600 $ 42,000  
Increase (Decrease) in the equity securities     $ 3,800     $ 1,000    
Cumulative upward fair value adjustments       $ 4,800        
Ascend                
Equity Securities without Readily Determinable Fair Value [Line Items]                
Investment in equity securities               $ 25,000
Conversion ratio         1      
Commitment to purchase convertible debt         $ 3,000      
Payment to acquire convertible notes         $ 2,100      
Redemption term         2 years      
Funded commitments, Annual interest rate         15.00%      
Funded commitments, redemption, multiplier         12      
Ascend | Participating stockholders in convertible note purchase | Ascend                
Equity Securities without Readily Determinable Fair Value [Line Items]                
Conversion ratio         1      
Ascend | Non-participating stockholders in convertible note purchase | Ascend                
Equity Securities without Readily Determinable Fair Value [Line Items]                
Conversion ratio         3      
Ascend Convertible Note Investment                
Equity Securities without Readily Determinable Fair Value [Line Items]                
Impairment loss on convertible note debt security   $ 3,000